Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by
significant morbidity and mortality, poor functional capacity and quality of life, and high costs …

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64
million people globally. Although the incidence of HF has stabilised worldwide and seems to …

Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is
increasing in prevalence. HF health expenditures are considerable and will increase …

Some population statistics suggested that the epidemiologic burden of heart failure (HF)
may have significantly decreased between 2000 and 2010. However, this trend could not be …

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of>
37.7 million individuals globally. HF is a shared chronic phase of cardiac functional …

Heart failure (HF) is a long‐term clinical syndrome, with increasing prevalence and
considerable healthcare costs that are further expected to increase dramatically. Despite …

Heart failure (HF) is a global public health concern with disproportionate socioeconomic,
morbidity and mortality burden on low-and middle-income countries (LMICs). This review …

Heart failure (HF) is a heterogenous and life-threatening syndrome that affects more than 60
million individuals globally and is characterised by severe morbidity and mortality, poor …

Heart failure (HF) is an epidemic in healthcare worldwide, including Asia. It appears that HF
will become more serious in the near future, with the epidemiological transition and ageing …

Heart failure (HF) is a major public health issue, with a prevalence of over 5.8 million in the
USA, and over 23 million worldwide, and rising. The lifetime risk of developing HF is one in …